eXoZymes Statistics

Total Valuation

eXoZymes has a market cap or net worth of $83.59 million. The enterprise value is $78.00 million.

Market Cap	83.59M
Enterprise Value	78.00M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

eXoZymes has 8.37 million shares outstanding. The number of shares has increased by 21.98% in one year.

Current Share Class	8.37M
Shares Outstanding	8.37M
Shares Change (YoY)	+21.98%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	25.64%
Owned by Institutions (%)	47.57%
Float	6.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.58
P/TBV Ratio	11.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.19.

Current Ratio	6.19
Quick Ratio	5.95
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -310.01% and return on invested capital (ROIC) is -86.16%.

Return on Equity (ROE)	-310.01%
Return on Assets (ROA)	-73.68%
Return on Invested Capital (ROIC)	-86.16%
Return on Capital Employed (ROCE)	-95.67%
Revenue Per Employee	n/a
Profits Per Employee	-$248,679
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2,144
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	10.71
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.40
Average Volume (20 Days)	4,971

Short Selling Information

The latest short interest is 17,006, so 0.20% of the outstanding shares have been sold short.

Short Interest	17,006
Short Previous Month	16,914
Short % of Shares Out	0.20%
Short % of Float	0.27%
Short Ratio (days to cover)	0.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.09M
Pretax Income	n/a
Net Income	-7.71M
EBITDA	-7.81M
EBIT	-8.09M
Earnings Per Share (EPS)	-$1.01

Full Income Statement

Balance Sheet

The company has $6.99 million in cash and $1.39 million in debt, giving a net cash position of $5.59 million or $0.67 per share.

Cash & Cash Equivalents	6.99M
Total Debt	1.39M
Net Cash	5.59M
Net Cash Per Share	$0.67
Equity (Book Value)	7.24M
Book Value Per Share	0.86
Working Capital	6.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.92 million and capital expenditures -$292,025, giving a free cash flow of -$9.21 million.

Operating Cash Flow	-8.92M
Capital Expenditures	-292,025
Free Cash Flow	-9.21M
FCF Per Share	-$1.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

eXoZymes does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.98%
Shareholder Yield	-21.98%
Earnings Yield	-9.22%
FCF Yield	-11.02%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1